Raphaël Chouinard-Watkins1, Valérie Conway1, Anne M Minihane2, Kim G Jackson3, Julie A Lovegrove3, Mélanie Plourde4. 1. Research Center on Aging, Health and Social Services Centre - University Institute of Geriatrics of Sherbrooke, Sherbrooke, Canada; Departments of Physiology and. 2. Department of Nutrition, Norwich Medical School, University of East Anglia, Norwich, United Kingdom; and. 3. Hugh Sinclair Unit of Human Nutrition and Institute for Cardiovascular and Metabolic Research, University of Reading, Reading, United Kingdom. 4. Research Center on Aging, Health and Social Services Centre - University Institute of Geriatrics of Sherbrooke, Sherbrooke, Canada; Departments of Physiology and Medicine, University of Sherbrooke, Sherbrooke, Canada; melanie.plourde2@usherbrooke.ca.
Abstract
BACKGROUND: Carriers of the apolipoprotein E ɛ4 (APOE4) allele are lower responders to a docosahexaenoic acid (DHA) supplement than are noncarriers. This effect could be exacerbated in overweight individuals because DHA metabolism changes according to body mass index (BMI; in kg/m²). OBJECTIVES: We evaluated the plasma fatty acid (FA) response to a DHA-rich supplement in APOE4 carriers and noncarriers consuming a high-saturated fat diet (HSF diet) and, in addition, evaluated whether being overweight changed this response. DESIGN: This study was part of the SATgenɛ trial. Forty-one APOE4 carriers and 41 noncarriers were prospectively recruited and consumed an HSF diet for 8-wk followed by 8 wk of consumption of an HSF diet with the addition of DHA and eicosapentaenoic acid (EPA) (HSF + DHA diet; 3.45 g DHA/d and 0.5 g EPA/d). Fasting plasma samples were collected at the end of each intervention diet. Plasma total lipids (TLs) were separated into free FAs, neutral lipids (NLs), and phospholipids by using solid-phase extraction, and FA profiles in each lipid class were quantified by using gas chromatography. RESULTS: Because the plasma FA response to the HSF + DHA diet was correlated with BMI in APOE4 carriers but not in noncarriers, the following 2 groups were formed according to the BMI median: low BMI (<25.5) and high BMI (≥25.5). In response to the HSF + DHA diet, there were significant BMI × genotype interactions for changes in plasma concentrations of arachidonic acid and DHA in phospholipids and TLs and of EPA in NLs and TLs (P ≤ 0.05). APOE4 carriers were lower plasma responders to the DHA supplement than were noncarriers but only in the high-BMI group. CONCLUSIONS: Our findings indicate that apolipoprotein E genotype and BMI may be important variables that determine the plasma long-chain PUFA response to dietary fat manipulation. APOE4 carriers with BMI ≥25.5 may need higher intakes of DHA for cardiovascular or other health benefits than do noncarriers.
BACKGROUND: Carriers of the apolipoprotein E ɛ4 (APOE4) allele are lower responders to a docosahexaenoic acid (DHA) supplement than are noncarriers. This effect could be exacerbated in overweight individuals because DHA metabolism changes according to body mass index (BMI; in kg/m²). OBJECTIVES: We evaluated the plasma fatty acid (FA) response to a DHA-rich supplement in APOE4 carriers and noncarriers consuming a high-saturated fat diet (HSF diet) and, in addition, evaluated whether being overweight changed this response. DESIGN: This study was part of the SATgenɛ trial. Forty-one APOE4 carriers and 41 noncarriers were prospectively recruited and consumed an HSF diet for 8-wk followed by 8 wk of consumption of an HSF diet with the addition of DHA and eicosapentaenoic acid (EPA) (HSF + DHA diet; 3.45 g DHA/d and 0.5 g EPA/d). Fasting plasma samples were collected at the end of each intervention diet. Plasma total lipids (TLs) were separated into free FAs, neutral lipids (NLs), and phospholipids by using solid-phase extraction, and FA profiles in each lipid class were quantified by using gas chromatography. RESULTS: Because the plasma FA response to the HSF + DHA diet was correlated with BMI in APOE4 carriers but not in noncarriers, the following 2 groups were formed according to the BMI median: low BMI (<25.5) and high BMI (≥25.5). In response to the HSF + DHA diet, there were significant BMI × genotype interactions for changes in plasma concentrations of arachidonic acid and DHA in phospholipids and TLs and of EPA in NLs and TLs (P ≤ 0.05). APOE4 carriers were lower plasma responders to the DHA supplement than were noncarriers but only in the high-BMI group. CONCLUSIONS: Our findings indicate that apolipoprotein E genotype and BMI may be important variables that determine the plasma long-chain PUFA response to dietary fat manipulation. APOE4 carriers with BMI ≥25.5 may need higher intakes of DHA for cardiovascular or other health benefits than do noncarriers.
Authors: Tao Huang; Tiange Wang; Yoriko Heianza; Yan Zheng; Dianjianyi Sun; Jae H Kang; Louis R Pasquale; Eric B Rimm; JoAnn E Manson; Frank B Hu; Lu Qi Journal: Am J Clin Nutr Date: 2019-03-01 Impact factor: 7.045
Authors: Frauke Beyer; Sharzhad Kharabian Masouleh; Julia M Huntenburg; Leonie Lampe; Tobias Luck; Steffi G Riedel-Heller; Markus Loeffler; Matthias L Schroeter; Michael Stumvoll; Arno Villringer; A Veronica Witte Journal: Hum Brain Mapp Date: 2017-04-11 Impact factor: 5.038
Authors: Kenna E Slim; David Vauzour; Noemi Tejera; Peter J Voshol; Aedin Cassidy; Anne Marie Minihane Journal: FASEB J Date: 2016-11-28 Impact factor: 5.191
Authors: Alex Pizzini; Lukas Lunger; Egon Demetz; Richard Hilbe; Guenter Weiss; Christoph Ebenbichler; Ivan Tancevski Journal: Nutrients Date: 2017-10-06 Impact factor: 5.717